- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/557 - ImmunoassayBiospecific binding assayMaterials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
Patent holdings for IPC class G01N 33/557
Total number of patents in this class: 273
10-year publication summary
13
|
18
|
29
|
17
|
17
|
16
|
20
|
33
|
22
|
21
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Hoffmann-La Roche Inc. | 3484 |
10 |
Howard Hughes Medical Institute | 229 |
8 |
Cytiva Sweden AB | 764 |
8 |
Access Medical Systems, Ltd. | 75 |
6 |
GE Healthcare Bio-Sciences AB | 540 |
6 |
Hound Labs, Inc. | 54 |
6 |
F. Hoffmann-La Roche AG | 7947 |
5 |
Genentech, Inc. | 4012 |
5 |
Abbott Diabetes Care Inc. | 2043 |
4 |
The Regents of the University of Michigan | 4753 |
4 |
Arizona Board of Regents on behalf of Arizona State University | 2678 |
4 |
The Brigham & Women's Hospital, Inc. | 45 |
4 |
Creoptix AG | 19 |
4 |
Juno Therapeutics GmbH | 41 |
4 |
Technische Universiteit Eindhoven | 354 |
4 |
Zomedica Biotechnologies LLC | 51 |
4 |
Inanovate, Inc. | 14 |
3 |
Ortho-Clinical Diagnostics, Inc. | 335 |
3 |
Siemens Healthcare Diagnostics Inc. | 2085 |
3 |
The Trustees of Indiana University | 759 |
3 |
Other owners | 175 |